“SAB is a very different company today than we were at the beginning of the year.” With unprecedented growth and a one-of-a-kind treatment for COVID-19, SAB Biotherapeutics is just getting started.
Whether patients have mild COVID-19 symptoms or are seriously ill, there’s a team at Sanford Research working to address and combat every step of the novel coronavirus.
She’s a scientist, a breast cancer survivor and now the inventor of a potentially game-changing test for cancer thanks to collaborations that show how far bioscience in Sioux Falls has come.
A new study from Sanford Research will try to determine the prevalence of COVID-19 and learn more about its antibodies.
Sanford Health’s research leader details the more than 15 clinical trials underway or planned to start within the health system for COVID-19 patients.
Sanford Health is celebrating a big boost in grant funding to support an undergraduate research internship program that already draws top students from around the world.
Sanford Research has hit a key milestone in its efforts to gain FDA approval for ground-breaking use of stem cells in orthopedics and is already pursuing new trials to broaden its efforts.
Some of the most accomplished researchers in the medical world will be in Sioux Falls next week, and one will leave with the first $1 million prize awarded by Sanford Health.
Here’s good news for researchers at Sanford Health and the state’s bioscience economy: A major grant from the National Institutes of Health has been renewed five more years.
They reversed blindness, helped children walk and set the standard for all gene therapy trials. Meet the finalists for Sanford’s first $1 million Lorraine Cross Award.
